Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala

Journal of Comparative Neurology

Volumn 517, Issue 2, 2009, Pages 166-176

  Rostkowski, Amanda B ^a   Teppen, Tara L ^a,b   Peterson, Daniel A ^a   Urban, Janice H ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anxiety; Calcium binding proteins; CaMKII; Interneuron; Pyramidal neuron

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALRETININ; CHOLECYSTOKININ; NEUROPEPTIDE Y1 RECEPTOR; PARVALBUMIN; SOMATOSTATIN;

AMYGDALOID NUCLEUS; ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RAT; STEREOLOGY;

AMYGDALA; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CHOLECYSTOKININ; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; NEURONS; NEUROPEPTIDE Y; PARVALBUMINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SOMATOSTATIN;

EID: 70349798589     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22143     Document Type: Article

References (76)

1. Adams JC. 1992. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 40:1457-1463.
2. Chung L, Moore SD. 2007. Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala. Neuropeptides 41:453-463.
3. Cui H, Sakamoto H, Higashi S, Kawata M. 2008. Effects of single-prolonged stress on neurons and their afferent inputs in the amygdala. Neuroscience 152:703-712.
4. Dumont Y, Fournier A, St Pierre S, Quirion R. 1993. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci 13:73-86.
5. Durkin MM, Walker MW, Smith KE, Gustafson EL, Gerald C, Branchek TA. 2000. Expression of a novel neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brain. Exp Neurol 165:90-100.
6. Erondu NE, Kennedy MB. 1985. Regional distribution of type II Ca2+/ calmodulin-dependent protein kinase in rat brain. J Neurosci 5:3270-3277.
7. Flood JF, Baker ML, Hernandez EN, Morley JE. 1989. Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res 503:73-82.
8. Füsezi T, Wittman G, Liposits Z, Lechan RM, Fekete C. 2007. Contribution of noradrenergic and adrenergic cell groups of the brainstem and agouti-related protein-synthesizing neurons of the arcuate nucleus to neuropeptide-Y innervation of corticotropin-releasing hormone neurons in hypothalamic paraventricular nucleus of the rat. Endocrinology 148:5442-5450.
9. Gadd CA, Murtra P, De Felipe C, Hunt SP. 2003. Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J Neurosci 23:8271-8280.
10. Gehlert DR, Schober DA, Morin M, Berglund MM. 2007. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties. Biochem Pharmacol 74:1652-1664.
11. Gundersen HJ, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263.
12. Gutman AR, Yang Y, Ressler KJ, Davis M. 2008. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci 28:12682-12690.
13. Hall E. 1972. The amygdala of the cat: a Golgi study. Z Zellforsch Mikrosk Anat 134:439-458.
14. Heilig M. 1995. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59:201-205.
15. Heilig M. 2004. The NPY system in stress, anxiety and depression. Neuropeptides 38:213-224.
16. Heilig M, Soderpalm B, Engel JA, Widerlov E. 1989. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl) 98:524-529.
17. Heilig M, McLeod S, Koob GK, Britton KT. 1992. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul Pept 41:61-69.
18. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT. 1993. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8:357-363.
19. Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjogren M, Asberg M, Ekman R, Wahlestedt C, Agren H. 2004. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 38:113-121.
20. Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA. 1992. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci U S A 89:5794-5798.
21. Isoardi NA, Bertotto ME, Martijena ID, Molina VA, Carrer HF. 2007. Lack of feedback inhibition on rat basolateral amygdala following stress or withdrawal from sedative-hypnotic drugs. Eur J Neurosci 26:1036-1044.
22. Karl T, Burne TH, Herzog H. 2006. Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behav Brain Res 167:87-93.
23. Karlsson RM, Holmes A, Heilig M, Crawley JN. 2005. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav 80:427-436.
24. Kask A, Rago L, Harro J. 1998. Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res 788:345-348.
25. Kask A, Nguyen HP, Pabst R, von Horsten S. 2001. Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. Neuroscience 104:799-806.
26. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R. 2002. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26:259-283.
27. Kemppainen S, Pitkanen A. 2000. Distribution of parvalbumin, calretinin, and calbindin-D(28k) immunoreactivity in the rat amygdaloid complex and colocalization with gamma-aminobutyric acid. J Comp Neurol 426:441-467.
28. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H, Hollenberg AN, Friedman JM, Elmquist JK. 2005. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 482:217-243.
29. Kopp J, Xu ZQ, Zhang X, Pedrazzini T, Herzog H, Kresse A, Wong H, Walsh JH, Hokfelt T. 2002. Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 111:443-532.
30. Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD. 1993. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur J Neurosci 5:1622-1637.
31. Marley PD, Rehfeld JF, Emson PC. 1984. Distribution and chromatographic characterisation of gastrin and cholecystokinin in the rat central nervous system. J Neurochem 42:1523-1535.
32. Martijena ID, Rodriguez Manzanares PA, Lacerra C, Molina VA. 2002. GABAergic modulation of the stress response in frontal cortex and amygdala. Synapse 45:86-94.
33. Mascagni F, McDonald AJ. 2003. Immunohistochemical characterization of cholecystokinin containing neurons in the rat basolateral amygdala. Brain Res 976:171-184.
34. McDonald AJ. 1982. Neurons of the lateral and basolateral amygdaloid nuclei: a Golgi study in the rat. J Comp Neurol 212:293-312.
35. McDonald AJ. 1985. Morphology of peptide-containing neurons in the rat basolateral amygdaloid nucleus. Brain Res 338:186-191.
36. McDonald AJ. 1989. Coexistence of somatostatin with neuropeptide Y, but not with cholecystokinin or vasoactive intestinal peptide, in neurons of the rat amygdala. Brain Res 500:37-45.
37. McDonald AJ. 1992. Projection neurons of the basolateral amygdala: a correlative Golgi and retrograde tract tracing study. Brain Res Bull 28:179-185.
38. McDonald AJ. 1997. Calbindin-D28k immunoreactivity in the rat amygdala. J Comp Neurol 383:231-244.
39. McDonald AJ, Betette RL. 2001. Parvalbumin-containing neurons in the rat basolateral amygdala: morphology and co-localization of Calbindin-D(28k). Neuroscience 102:413-425.
40. McDonald AJ, Mascagni F. 2001a. Colocalization of calcium-binding proteins and GABA in neurons of the rat basolateral amygdala. Neuroscience 105:681-693.
41. McDonald AJ, Mascagni F. 2001b. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 107:641-652.
42. McDonald AJ, Mascagni F. 2002. Immunohistochemical characterization of somatostatin containing interneurons in the rat basolateral amygdala. Brain Res 943:237-244.
43. McDonald AJ, Mascagni F. 2007. Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala. Neuroscience 146:306-320.
44. McDonald AJ, Pearson JC. 1989. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci Lett 100:53-58.
45. McDonald AJ, Muller JF, Mascagni F. 2002. GABAergic innervation of alpha type II calcium/calmodulin-dependent protein kinase immunoreactive pyramidal neurons in the rat basolateral amygdala. J Comp Neurol 446:199-218.
46. McDonald AJ, Mascagni F, Mania I, Rainnie DG. 2005. Evidence for a perisomatic innervation of parvalbumin-containing interneurons by individual pyramidal cells in the basolateral amygdala. Brain Res 1035: 32-40.
47. Morin SM, Gehlert DR. 2006. Distribution of NPY Y5-like immunoreactivity in the rat brain. J Mol Neurosci 29:109-114.
48. Muller JF, Mascagni F, McDonald AJ. 2003. Synaptic connections of distinct interneuronal subpopulations in the rat basolateral amygdalar nucleus. J Comp Neurol 456:217-236.
49. Muller JF, Mascagni F, McDonald AJ. 2006. Pyramidal cells of the rat basolateral amygdala: synaptology and innervation by parvalbumin-immunoreactive interneurons. J Comp Neurol 494:635-650.
50. Muller JF, Mascagni F, McDonald AJ. 2007a. Postsynaptic targets of somatostatin-containing interneurons in the rat basolateral amygdala. J Comp Neurol 500:513-529.
51. Muller JF, Mascagni F, McDonald AJ. 2007b. Serotonin-immunoreactive axon terminals innervate pyramidal cells and interneurons in the rat basolateral amygdala. J Comp Neurol 505:314-335.
52. Oberto A, Acquadro E, Bus T, Sprengel R, Eva C. 2007. Expression patterns of promoters for NPY Y1 and Y5 receptors in Y5RitTA and Y1RVenus BAC-transgenic mice. Eur J Neurosci 26:155-170.
53. Pare D, Collins DR. 2000. Neuronal correlates of fear in the lateral amygdala: multiple extracellular recordings in conscious cats. J Neurosci 20:2701-2710.
54. Parker RM, Herzog H. 1999. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11:1431-1448.
55. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press.
56. Pesold C, Treit D. 1995. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 671:213-221.
57. Peterson DA. 1999. Quantitative histology using confocal microscopy: implementation of unbiased stereology procedures. Methods 18:493-507.
58. Pitkanen A. 2000. Connectivity of the rat amygdaloid complex. In: Aggleton JP, editor. The amygdala: a functional analysis. New York: Oxford University Press. p 31-115.
59. Radulovic J, Ruhmann A, Liepold T, Spiess J. 1999. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19:5016-5025.
60. Rainnie DG, Mania I, Mascagni F, McDonald AJ. 2006. Physiological and morphological characterization of parvalbumin-containing interneurons of the rat basolateral amygdala. J Comp Neurol 498:142-161.
61. Redrobe JP, Dumont Y, Fournier A, Quirion R. 2002. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26:615-624.
62. Rodriguez Manzanares PA, Isoardi NA, Carrer HF, Molina VA. 2005. Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. J Neurosci 25:8725-8734.
63. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A. 1999a. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 100:207-215.
64. Sajdyk TJ, Vandergriff MG, Gehlert DR. 1999b. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368:143-147.
65. Sajdyk TJ, Johnson PL, Leitermann RJ, Fitz SD, Dietrich A, Morin M, Gehlert DR, Urban JH, Shekhar A. 2008. Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J Neurosci 28:893-903.
66. Schmitz C, Hof PR. 2005. Design-based stereology in neuroscience. Neuroscience 130:813-831.
67. Schwaller B, Bruckner G, Celio MR, Hartig W. 1999. A polyclonal goat antiserum against the calcium-binding protein calretinin is a versatile tool for various immunochemical techniques. J Neurosci Methods 92:137-144.
68. Selbie LA, Hill SJ. 1998. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. TINS 19:87-93.
69. Smagin GN, Dunn AJ. 2000. The role of CRF receptor subtypes in stress-induced behavioural responses. Eur J Pharmacol 405:199-206.
70. Sorensen G, Lindberg C, Wortwein G, Bolwig TG, Woldbye DP. 2004. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J Neurosci Res 77:723-729.
71. Sorvari H, Miettinen R, Soininen H, Paljarvi L, Karkola K, Pitkanen A. 1998. Calretinin-immunoreactive terminals make synapses on calbindin D28k-immunoreactive neurons in the lateral nucleus of the human amygdala. Brain Res 783:355-358.
72. Sosulina L, Schwesig G, Seifert G, Pape HC. 2008. Neuropeptide Y activates a G-protein-coupled inwardly rectifying potassium current and dampens excitability in the lateral amygdala. Mol Cell Neurosci 39: 491-498.
73. Stork O, Ji FY, Obata K. 2002. Reduction of extracellular GABA in the mouse amygdala during and following confrontation with a conditioned fear stimulus. Neurosci Lett 327:138-142.
74. Szabat E, Soinila S, Happola O, Linnala A, Virtanen I. 1992. A new monoclonal antibody against the GABA-protein conjugate shows immunoreactivity in sensory neurons of the rat. Neuroscience 47:409-420.
75. Washburn MS, Moises HC. 1992. Electrophysiological and morphological properties of rat basolateral amygdaloid neurons in vitro. J Neurosci 12:4066-4079.
76. Wolak ML, DeJoseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH. 2003. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 464:285-311.